Sanofi India received a final income tax assessment order for FY 2022-23 (AY 2023-24) on 27th March 2026.
The Assessment Unit determined a tax liability of INR 12,36,99,710 (including interest) on transfer pricing and HCP payment disallowances.
The company intends to file an appeal before Higher Tax Authorities against the adjustments and disallowances made.